Allogene Therapeutics
Clinical trials sponsored by Allogene Therapeutics, explained in plain language.
-
Experimental cell therapy enters human testing for Tough-to-Treat kidney cancer
Disease control OngoingThis early-stage trial is testing the safety and finding the right dose of an experimental cell therapy called ALLO-316 for people with advanced kidney cancer that has spread. The study involves 120 adults whose cancer has progressed despite standard treatments. Researchers are g…
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 01:50 UTC
-
New 'Ready-Made' cell therapy tested for tough blood cancers
Disease control OngoingThis study is testing a new type of cell therapy called ALLO-501A for adults with large B-cell lymphoma or CLL/SLL that has come back or hasn't responded to other treatments. The goal is to see if this 'off-the-shelf' therapy, made from donor cells instead of the patient's own, i…
Phase: PHASE1, PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC